Sofinnova Partners

Venture Capital Exempt reporting adviser

Legal name: Sofinnova Partners Sas

AUM

$1.9B

Private fund assets

Private funds

Venture Capital 16 · Private Equity 2

Private fund assets

$1.9B

Gross asset value

Employees

—

Last Form D raise

Nov 2024

Most recent fund filing

From SEC Form ADV filing (filed Mar 27, 2026). View on SEC

Investment focus

As listed in industry directories; may be out of date.

First check: $1.0M
Stages: Pre-SeedSeries AGrowth
Sectors: Life Sciences & Healthtech
Geographies: FranceItalyUSAGermanyNetherlandsCanadaSwitzerlandUKUnited Kingdom

Owners and executive officers named on the firm's SEC Form ADV.

Managing Partner and Chairman

Managing Partner

Managing Partner, Societe Civile Montclair

Managing Partner, Societe Civile Montclair

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

Fund	Type	Gross assets	Raised (Form D)	Investors	Last Form D	Recency
Sofinnova Capital XI Scsp Sicav-Raif	Venture Capital	$10.3M	$54.0M	2	Nov 2024	Cool
Sofinnova Crossover I	Private Equity	$609.9M	—	—	—
Sofinnova Capital IX	Venture Capital	$255.3M	—	—	—
Sofinnova Capital VIII	Venture Capital	$246.3M	—	—	—
Sofinnova Capital X	Venture Capital	$207.1M	—	—	—
Sofinnova MD Start III	Venture Capital	$101.2M	—	—	—
Sofinnova Digital Medicine I	Venture Capital	$91.6M	—	—	—
Sofinnova Industrial Biotech II	Venture Capital	$90.2M	—	—	—
Sofinnova Industrial Biotech I	Venture Capital	$73.5M	—	—	—
Sofinnova Telethon Sca Raif	Venture Capital	$62.8M	—	—	—
Sofinnova Capital VII	Venture Capital	$24.1M	—	—	—
Sofinnova Green Seed Fund	Venture Capital	$24.0M	—	—	—
Sofinnova Capital VI	Venture Capital	$22.5M	—	—	—
Sofinnova Coiv Eif	Venture Capital	$13.3M	—	—	—
Sofinnova Crossover II	Private Equity	$13.2M	—	—	—

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.